Entinostat Plus Pembrolizumab Shows Promise in Previously Treated Melanoma
Source: Modern Medicine Network, May 2019 Cancer Network spoke with Ryan J. Sullivan, MD, about the efficacy and safety of entinostat plus pembrolizumab in patients previously treated with immunotherapy. Read More
Dr. Johnson on Promise of Combination Therapy in Melanoma
Source: OncLive, May 2019 Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy…
Read More Dr. Sullivan on Findings From the ENCORE 601 Trial in Melanoma
Source: OncLive, May 2019 Ryan J. Sullivan, MD, assistant professor of medicine, Harvard Medical School, assistant professor of medicine, Hematology/Oncology, Massachusetts General Hospital (MGH), MGH Cancer Center, discusses findings from…
Read More VIDEO: Meeting highlights treatment advances, challenges in melanoma
Source: Healio, May 2019 NEW YORK — This year’s HemOnc Today New York meeting included a session dedicated to treatment advances and challenges in melanoma Speakers addressed genetic testing for high-risk patients,…
Read More